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Abstract
Background: To investigate the adherence and the factors in the 
literature associated with the use of oral anticoagulants.
Method: This is an integrative review conducted in the databases: 
COCHRANE, Scientific Electronic Library Online, Latin American and 
Caribbean Sciences Health, Cumulative Index to Nursing and Allied 
Health Literature, National Library of Medicine and National Institutes 
of Health and Web of Science in June 2015.
Results: The sample consisted of 16 publications of which 4 (25%) 
were found in database LILACS, 4 (25%) in the CINAHL, 5 (31.2%) 
in the WEB OF SCIENCE and 3 (18.8%) in PUBMED. Most of the 
studies showed poor adherence to oral anticoagulant therapy and 
clinical, psychological, socioeconomic factors as influencers in the 
adherence.
Conclusions: Joining the treatment is shown to be essential for pro-
per control of any illness, a phenomenon that is evident by the active 
participation of the patient in the therapeutic plan.
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With the high life expectancy and changes in the epidemiological 
profile, there was an increased use of oral anticoagulant therapy 
(OAT) in various situations in clinical practice due to its proven effi-
cacy and safety in the prevention and treatment of thromboembolic 
events. On the other hand, there is great variability in individual res-
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ponses to OAT that may trigger unwanted effects, 
such as bleeding and thrombus. [1]
Therapy with the OAT is often indicated in si-
tuations such as acute myocardial infarction, atrial 
fibrillation, deep vein thrombosis, prosthetic heart 
valves, stroke, among other special situations. The 
Coumadin derivate drugs act on the physiological 
process of hemostasis system, reducing the activity 
of vitamin K and thereby slowing clot formation 
time. [2]
In this perspective, the use of these drugs re-
quires a medical control and rigorous service by 
health professionals, requiring that patients using 
the therapy undergo periodic laboratory tests to 
assess the proper dosage. The laboratory moni-
toring is performed by frequent blood sampling 
to obtain the international normalized ratio (INR), 
ranging from 2 to 3 or according to directions for 
anticoagulation. [1]
Studies show that the OAT therapeutic action can 
be influenced by several situations, such as drug 
interactions, food, genetic factors, vitamin K intake 
and the presence of comorbidities, thus interfering 
with the drug stability. This care can cause changes 
in the lifestyle of the patients since there are chan-
ges in eating habits and the peculiarities inherent 
to the therapy, as the habit of daily intake of the 
drug and the need for monitoring of anticoagula-
tion range in health services. [3]
Given that this monitoring occurs for an exten-
ded period, it is essential the patient adherence to 
the therapeutic process prevent the emergence of 
possible complications and ensure a safe treatment, 
being an important factor to be considered together 
with the associated factors that can interfere with 
this process.[3]
Facing all these care demands that the treatment 
with OAT generates, there is the role of the health 
professionals, especially the nurses, being an extre-
mely important subject in promoting OAT therapy 
guidelines, essential for the adherence of these pa-
tients and therefore their quality of life.
Thus, this study aimed to verify the adherence 
to therapy with OAT and associated factors in the 
literature.
Methods
This study is an integrative review. For the imple-
mentation of this integrative review, there was the 
drafting of a protocol where the following steps 
were followed: definition of research question and 
objective; establishment of criteria for inclusion and 
exclusion of articles (sample selection); databases, 
descriptors used in the search, descriptors crossing, 
strategy for data collection of articles and critical 
evaluation of studies.[4]
The elaboration of the research question was 
based on PVO strategy (P- problem; V- variables; 
O- outcome). Thus, the question prepared for the 
study was: “What is the production in the literature 
on patient adherence to therapy with oral anticoa-
gulants and associated factors?”
For the survey of articles in the literature, a search 
was held in June 2015, using the databases: CO-
CHRANE, Scientific Electronic Library Online (SCIE-
LO), Latin American and Caribbean Health Sciences 
(LILACS), Cumulative Index to Nursing and Allied 
Health Literature (CINAHL), National Library of Me-
dicine and National Institutes of Health (PUBMED) 
and Web of Science.
The following descriptors were defined: medi-
cation adherence and anticoagulants. They were 
grouped in an uncontrolled way and using Boolean 
operator “AND”. During the survey of the publica-
tions, uncontrolled descriptors of MeSH vocabulary 
were used - Medication Adherence and anticoagu-
lants.
After inserting the search expressions in the data-
bases, the search limits were: publications available 
in full in the above databases and answering the 
guiding question. There was not date restriction of 
publications. Studies of literature reviews were ex-
cluded.
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The study selection procedure was performed by 
two researchers independently, based on the re-
search protocol, the analysis of the titles and abs-
tracts of the publications. Later, there was a consen-
sus of the articles that would be read in full from 
the previously selected studies. (Figure 1)
The results were presented descriptively in two 
steps. The first step was the data description of 
the publications identification (database, study type, 
year of publication, the level of scientific evidence 
according to Joanna Briggs Institute and country 
of the study). In the second step, adherence and 
factors associated with this therapy adherence in 
the OAT were described. Therefore, the results were 
grouped into two categories: adherence medication 
therapy with OAT and factors related to adherence 
to the OAT.
Results 
Out of the six surveyed bases, Scielo and Cochrane 
did not add any studies to the sample. The sample 
of this review totaled of 16 articles (Table 1), of 
which 4 (25%) were found in LILACS database, 4 
(25%) in the CINAHL, 5 (31.2%) in WEB OF SCIENCE 
and 3 (18.8%) in PubMed.
Of the studies analyzed, 10 (62.50%) were publis-
hed in the period from 2011 to 2015 and 6 (37.50%) 
from 2007 to 2010. As for the origin of the study, 6 
(37.50%) were from the United States, 4 (25.00%) 
from Brazil, 1 (6.25%) from the UK, 6.25%), 1 from 
Table 1. Characterization of the articles found. Natal/RN, Brazil, in 2015.
Database [Reference] Type of study
Year of 
Publication
Level of 
Evidence*
Country of the study
PUBMED [5] Prospective cohort study 2007 2b USA
PUBMED [6] Prospective cohort study 2010 2b USA
Web of Science [7] Cross-sectional study 2011 4b The Republic of Korea
Web of Science [8] Case-control study 2014 4b Italy
Web of Science [9] Prospective observational cohort study 2015 2b Germany
CINAHL [10] Cohort study 2014 2b USA
CINAHL [11] Prospective cohort study 2010 2b USA
CINAHL [12] Prospective cohort study 2011 2b USA
Figure 1:  Flowchart of the methodological steps 
of the integrative review. Natal, 2015.
Articles excluded from the initial search
Crossing results
“Medication adherence AND anticoagulants”
SCIELO (n=0)
LILACS (n=5)
- Out of the theme (n=1)
Crossing results
“Medication adherence AND anticoagulants”
COCHRANE (n=20)
- Not available in full (n=19)
- Out of the theme (n=1)
CINAHL (n=139)
- Not available in full (n=3)
- N Out of the theme (n=132)
PUBMED (n=265) 
- Not available in full (n=186)
- Out of the theme (n=51)
- Repeated (n=3)
Web of Science (n=94) 
- Not available in full (n=55)
- Review studies (n=13)
Articles identified in the initial search (n=523)
Selected articles (n=16)
Pre-selected articles (n=38)
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Singapore, 1 (6.25%) from Germany, 1 (6.25%) 
from Italy, 1 (6.25%) from the Republic of Korea 
and 1 (6.25%) from Finland.
The articles were published in 14 different jour-
nals, 12 (75.00%) International journals and 4 
(25,00%) national journals. Regarding the langua-
ge of the studies, 13 (81.20%) were published in 
English and 3 (18.80%) in Portuguese.
As for the level of evidence, most of the studies 
are classified according to the Joanna Briggs Insti-
tute as evidence level 2b (50%), 4b (43.4%) and 
4c (6.35%). Low adherence was observed in most 
studies, 9 (56.25%). (Table 2)
To measure this adherence, the studies used some 
resources, such as 1 drug count (6.25%), 1 moni-
toring by phone (6.25%), 2 self-reported (12.50%), 
3 Morisky Adherence Scale (18.75%), 4 INR dosa-
ge (25.00%) and 5 electronic monitoring (31.25%). 
(Table 3)
Discussions 
Although in recent years, the benefit and safety of 
the use of therapy with ACO have been established 
for the prophylaxis and treatment of thromboem-
bolic events, its adherence in clinical practice has 
not been significant [14], as observed in this study, 
remaining a major challenge.
Patient adherence to therapy consists of a colla-
borative process of an individual against the pro-
posed treatment, corresponding to the guidelines 
recommended by health professionals, facilitating 
the acceptance and integration of a given treatment 
regimen. [21] According to the World Health Orga-
nization, the nonadherence to long-term therapies 
in developed countries is around 50%, and this per-
centage in developing countries is higher. [22]
A study conducted at the state hospital in Ri-
beirão Preto assessing the adherence to treatment 
Database [Reference] Type of study
Year of 
Publication
Level of 
Evidence*
Country of the study
Web of Science [13] Cross-sectional study 2014 4b Singapur
LILACS [14] Cross-sectional study 2011 4b Brazil
LILACS [15] Cross-sectional study 2009 4b Brazil
LILACS [16] Methodological study 2010 4c Brazil
LILACS [17] Retrospective cohort study 2014 2b Brazil
PUBMED [18] Case-control study 2008 4b USA
Web of Science [19] Cohort study 2015 2b United Kingdom
CINAHL [20] Cross-sectional study 2011 4b Finland
*: Level of Evidence: Joanna Briggs Institute.
Table 2.  Adherence to OAT according to the studies 
of the integrative review. Natal/RN, Brazil, 
in 2015.
Adherence to 
treatment
Estudos n %
Low 5, 6, 7, 8, 9, 10, 11, 12, 13 9 56.25
Mean 14, 15 2 12.50
High 16, 17, 18, 19, 20 5 31.25
Table 2.  Factors associated with adherence of OAT 
according to the integrative review. Natal/
RN, Brazil, in 2015.
Associated factors Studies n %
Clinical factors (Long period of 
anticoagulation and outpatient 
follow-up, complications)
5, 6, 8, 11, 
13, 14, 15, 17
8 50.00
Psychosocial factors (Change 
of health, knowledge of the 
importance of therapy, lack 
of encouragement by health 
professionals).
6, 7, 11 3 18.75
Socioeconomic factors (Level of 
education, cost of medication 
and transportation, age).
6, 11, 14, 
15, 18
5 31.25
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of OAT in patients treated at a specialized anticoa-
gulation outpatient, two months after hospital dis-
charge, through an instrument called measure of 
adherence to treatment (MAT), all participants clas-
sified as compliant [3], in contrast with the results 
of this review.
It is important to note that a large number of 
drugs and daily doses are increasingly common in 
therapeutic regimens, and each new daily dose in-
troduced in the treatment, for a continuous period, 
leads to a direct reduction in medication adherence 
rate. [23] Thus, it is assumed that the adherence of 
the participants of the above study [3] can be ex-
plained by the short time analyzed regimen.
In the meantime, there are factors that can inter-
fere with adherence to treatment, such as advanced 
age, socioeconomic factors, fear of possible com-
plications, low level of education, the need for the 
drug intake every day, recurrent ambulatory mo-
nitoring, food and drug interaction, self-perceived 
health status [3, 24] corroborating the findings of 
this research, where clinical and socioeconomic fac-
tors were found to be more prevalent.
The cost of the medication was seen as a ma-
jor obstacle to adherence. [12, 13] Studies show 
that patients who presented satisfactory adherence 
spent less money on the drug compared to those 
who had average or low adherence. The high cost 
of medicine, transportation expenses for mobility 
to the health service and the long treatment were 
also identified as predisposing factors for low me-
dication adherence. [10, 11]
Furthermore, as the clinical factors, the prolon-
ged period of anticoagulation, the possible compli-
cations and the need for frequent laboratory control 
were identified as obstacles that hinder the conti-
nuity of treatment. [5, 6, 8, 11, 13, 15, 17]
The literature suggests that the laboratory control 
should be done every one or two days until the 
INR therapeutic is achieved. When the INR stabi-
lizes, the control should be weekly and after that 
monthly, even patients who maintain the stability 
of therapeutic anticoagulation levels should under-
go INR evaluation monthly. It is noteworthy that 
individual aspects, such as instability unexplained 
and comorbidities should establish other intervals 
between returns and assessments. [3]
These barriers are added when considering the 
factors associated with the health service, as the 
service is provided, receiving visits from family 
health team, patient-professional communication, 
the orientation of patients about the risks and be-
nefits of treatment, among others. [24]
Some measures have been adopted to try to re-
verse the situation to improve adherence to thera-
py, being essential to establish reliable relationships 
between the user and professionals, as well as cla-
rity of the recommendations. [21]
From this perspective, it is clear that nurses in 
clinical practice are faced increasingly with patients 
using OAT under their care, and therefore, it is ne-
cessary for the patient and this professional esta-
blish a mutual relationship of partnership, where the 
nurse seeks to involve the patient in the therapeu-
tic process, helping him to understand the need to 
take changes in his lifestyle, contributing to reducing 
complications and better treatment adherence. [25]
Thus, adhering to treatment is shown as a key 
factor for proper control of any disease, a phenome-
non that is evidenced by the active participation of 
the patient in treatment. In this context, the nurse 
together with the multidisciplinary team is essential 
to promote health education activities to minimize 
the factors that interfere with the continuity of the-
rapy since the adherence, and INR stability is funda-
mental to successful treatment. [15, 26]
Conclusions
From the found scientific production, it was found 
that most articles showed poor adherence to thera-
py with the OAT and identified factors that influen-
ce this discontinuation of drug treatment, such as 
psychosocial, socioeconomic, comorbidities, educa-
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tion level, fear of complications and long treatment 
therapy demand, among others.
Thus, it is realized that a collaboration between 
patients and health professionals should be stren-
gthened to improve adherence to health systems. 
Dialogue with patients can help in understanding 
motivation problems and helping health professio-
nals to provide adequate care for these patients, 
helping them gain a sense of normalcy and impro-
ving adherence, reducing the difference found bet-
ween what is proposed and the reality of clinical 
practice.
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